. "6 Methods for Predicting and Assessing Unintended Effects on Human Health." Safety of Genetically Engineered Foods: Approaches to Assessing Unintended Health Effects. Washington, DC: The National Academies Press, 2004.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Safety of Genetically Engineered Foods: Approaches to Assessing Unintended Health Effects
Taylor SL. 2001. Safety assessment of genetically modified foods. J Nematol 33:178–182.
Taylor SL. 2002. Protein allergenicity assessment of foods produced through agricultural biotechnology. Annu Rev Pharmacol Toxicol 42:99–112.
Taylor SL, Hefle SL. 2002. Food allergy assessment for products derived through plant biotechnology. In: Thomas JA, Fuchs RL, eds. Biotechnology and Safety Assessment. 3rd ed. San Diego: Academic Press. Pp. 325–345.
Thomas JG, Olson JM, Tapscott SJ, Zhao LP. 2001. An efficient and robust statistical modeling approach to discover differentially expressed genes using genomic expression profiles. Genome Res 11:1227–1236.
Thornquist MD, Kristal AR, Patterson RE, Neuhuser ML, Rock CL, Neumark-Sztainer D, Cheskin LJ. 2000. Olestra consumption does not predict serum concentrations of carotenoids and fatsoluble vitamins in free-living humans: Early results from the sentinel site of the Olestra postmarketing surveillance study. J Nutr 130:1711–1718.
Tollefson L, Barnard RJ. 1992. An analysis of FDA passive surveillance reports of seizures associated with consumption of aspartame. J Am Diet Assoc 92:598–601.
Vedavanam K, Srijayanta S, O’Reilly J, Raman A, Wiseman H. 1999. Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE). Phytother Res 13:601–608.
Vergriese AJ. 1972. Dietary fat and cardiovascular disease: Possible modes of action of linoleic acid. Proc Nutr Soc 31:323–329.
Vesselinovitch SD, Rao KV, Mihailovich N. 1979. Neoplastic response of mouse tissues during perinatal age periods and its significance in chemical carcinogenesis. J Natl Cancer Inst Monogr 51:239–250.
Westrate JA, van het Hof KH. 1995. Sucrose polyester and plasma carotenoid concentrations in healthy subjects. Am J Clin Nutr 62:591-597.
WHO (World Health Organization). 1993. Health aspects of marker genes in genetically modified plants. Report of a WHO Workshop, Copenhagen, Denmark, September 21-24. Geneva, Switzerland: World Health Organization.
WHO. 1996. Trace Elements in Human Nutrition and Health. Geneva: WHO.
Willett W. 1998. Nutritional Epidemiology. 2nd ed. Oxford: Oxford University Press.
Willett WC, Ascherio A. 1994. Trans fatty acids: Are the effects only marginal? Am J Public Health 84:722–724.
Xu XL, Olson JM, Zhao LP. 2002. A regression-based method to identify differentially expressed genes in microarray time course studies and its application to an inducible Huntington’s disease transgenic model. Hum Mol Genet 11:1977–1985.
Ye X, Al-Babili S, Kloti A, Zhang J, Lucca P, Beyer P, Potrykus I. 2000. Engineering the provitamin A (β-carotene) biosynthetic pathway into (carotenoid-free) rice endosperm. Science 287:303–305.
Yusuf S, Dagnenais G, Pogue J, Bosch J, Sleight P. 2000. Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 342:154–160.
Zitnak A, Johnston GR. 1970. Glycoalkaloid content of B5141-6 potatoes. Am Potato J 47:256–260.